Accelerated Resolution Therapy for Complicated Grief
1 other identifier
interventional
54
1 country
1
Brief Summary
This study will examine whether accelerated resolution therapy (ART) is effective for the treatment of prolonged and complicated grief and associated psychological trauma among older adult hospice caregivers who have experienced the death of an immediate family member at least 12 months ago.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 20, 2018
CompletedFirst Submitted
Initial submission to the registry
March 8, 2018
CompletedFirst Posted
Study publicly available on registry
March 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2019
CompletedDecember 7, 2020
December 1, 2020
1.4 years
March 8, 2018
December 3, 2020
Conditions
Outcome Measures
Primary Outcomes (3)
change in complicated grief symptoms
Response on the 19-item Inventory of Complicated Grief (ICF) over the course of the 4-week intervention period. Scores range from 0-76 with a score \>24 indicating presence of complicated grief.
4 weeks, follow up at 12 weeks
change in psychological trauma
The PCL-5 (PTSD Patient Checklist)26 is a 20-item self-report instrument that will be used to assess the DSM-5 symptoms of PTSD (psychological trauma)(corresponding to criteria B-E). The total symptom severity score ranges from 0 to . A diagnostic cut-point for PTSD of 33 has been recommended. In addition, it is generally accepted that a reduction of 10 points or more on the PCL-5 is indicative of statistical and clinically meaningful improvement.
4 weeks, follow up at 12 weeks
change in depressive symptoms
The Center for Epidemiologic Studies Depression Scale(CES-D)37is a widely used 20-item scale that has proven useful both as a screening instrument to detect individuals at risk for depression, and to measure the symptoms of depression.
4 weeks, follow up at 12 weeks
Secondary Outcomes (1)
change in stress response
weekly pre to post ART and over the 4 week intervention period
Study Arms (2)
Intervention
EXPERIMENTALWait list controlled
ACTIVE COMPARATORInterventions
ART is an evidence-based therapy for the treatment of depressive symptoms and trauma and stress-related disorders that includes the core components of trauma-focused therapy including imaging rescripting, voluntary image replacement, guided visualization with use of eye movements, desensitization and processing of distressing memories, and in-vitro exposure to future feared triggers
Eligibility Criteria
You may qualify if:
- Adult age 60 years of age or older
- previous primary caregiver of immediate family member who died after enrollment in hospice with the death occurring at least 12 months prior to enrollment
- current symptoms indicative of proposed diagnostic criteria for complicated grief disorder, as proposed by Shear et al. (2011)
- current score of \>25 on the 19-item Inventory of Complicated Grief
- current symptoms indicative of significant psychological trauma, as documented by score \>33on the 20-item DSM-5 PTSD checklist (PCL-5)26 or score \>4 on the PDSQ PTSD subscale
- denial of suicidal ideation or intent, with no evidence of psychotic behavior
You may not qualify if:
- engaged in another psychotherapy regimen that could also influence symptoms of PCG - - major psychiatric disorder (e.g. bipolar disorder) deemed likely to interfere with treatment delivery
- current substance abuse dependence (alcohol and/or drug) treatment anticipated to interfere with treatment delivery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Harleah Buck
Tampa, Florida, 33612, United States
Related Publications (1)
Buck HG, Benitez B, Mason T, Hernandez D, Tofthagen C, Mogle J. Exploring the role of expectancy in older US participants' response to an accelerated resolution therapy intervention for prolonged grief disorder. Health Soc Care Community. 2022 Nov;30(6):e4191-e4198. doi: 10.1111/hsc.13813. Epub 2022 Apr 9.
PMID: 35396879DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Harleah Buck, PhD
University of South Florida
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Distinguished Professor
Study Record Dates
First Submitted
March 8, 2018
First Posted
March 30, 2018
Study Start
February 20, 2018
Primary Completion
July 31, 2019
Study Completion
October 30, 2019
Last Updated
December 7, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share